ALXN - Alexion Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Cash flows from operating activities
Net Income
1,333,600
77,600
443,300
399,000
144,385
Depreciation & amortization
397,000
405,300
496,700
396,000
166,621
Deferred income taxes
-119,400
32,900
-45,900
104,000
395,495
Stock based compensation
215,400
203,000
243,100
192,000
227,133
Change in working capital
-430,400
-434,200
-170,500
-136,000
-415,171
Accounts receivable
-268,200
-208,800
-55,200
-122,000
-115,812
Inventory
-34,600
-14,700
-88,200
-84,000
-88,375
Accounts Payable
-
-
131,700
150,000
-115,938
Other working capital
1,264,400
213,000
758,300
753,000
388,864
Other non-cash items
-3,000
179,100
30,100
46,000
60,299
Net cash provided by operating activites
1,438,800
426,000
1,115,600
1,086,000
675,199
Cash flows from investing activities
Investments in property, plant and equipment
-174,400
-213,000
-357,300
-333,000
-286,335
Acquisitions, net
-
-
0
0
-3,939,307
Purchases of investments
-280,600
-805,100
-1,658,700
-675,000
-534,703
Sales/Maturities of investments
573,400
1,485,800
1,097,600
722,000
1,169,698
Other investing activites
400
2,800
100
-1,000
5,474
Net cash used for investing activites
118,800
470,500
-918,300
-287,000
-3,585,173
Cash flows from financing activities
Debt repayment
-282,700
-293,800
-175,000
-375,000
-301,250
Common stock issued
43,200
47,300
85,900
37,000
81,982
Common stock repurchased
-48,900
-85,000
-463,600
-430,000
-327,699
Dividends Paid
-
-
-
-
-
Other financing activites
-11,000
-20,900
-43,900
-68,000
-167,956
Net cash used privided by (used for) financing activities
-299,400
-102,400
-596,600
-836,000
2,985,077
Net change in cash
1,253,800
782,900
-381,600
-44,000
66,112
Cash at beginning of period
732,800
584,400
966,000
1,010,000
943,999
Cash at end of period
1,991,000
1,367,300
584,400
966,000
1,010,111
Free Cash Flow
Operating Cash Flow
1,438,800
426,000
1,115,600
1,086,000
675,199
Capital Expenditure
-174,400
-213,000
-357,300
-333,000
-286,335
Free Cash Flow
1,264,400
213,000
758,300
753,000
388,864